Effects of ketoconazole on the erythromycin breath test and the dapsone recovery ratio [1]

British Journal of Clinical Pharmacology

Volumn 47, Issue 2, 1999, Pages 223-225

  Kinirons, M T ^a   Krivoruk, Y ^a   Wilkinson, G R ^a   Wood, A J J ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 14; CYTOCHROME P450; CYTOCHROME P450 3A; DAPSONE; ERYTHROMYCIN; KETOCONAZOLE; UNCLASSIFIED DRUG;

ADULT; BLADDER CANCER; BREATH ANALYSIS; CANCER RISK; CLINICAL TRIAL; CONCENTRATION RESPONSE; DIAGNOSTIC VALUE; DRUG METABOLISM; ENZYME ACTIVITY; ENZYME LOCALIZATION; HUMAN; HUMAN EXPERIMENT; INTESTINE EPITHELIUM; LETTER; LIVER; NORMAL HUMAN; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

ADULT; ARYL HYDROCARBON HYDROXYLASES; BREATH TESTS; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DAPSONE; ERYTHROMYCIN; HUMANS; KETOCONAZOLE; OXIDOREDUCTASES, N-DEMETHYLATING; PLACEBOS;

EID: 0032987001     PISSN: 03065251     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2125.1999.00859.x     Document Type: Letter

References (18)